Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 301 to 308 of 308 entries
Sorted by: Best Match Show Resources per page
Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia.

Hypertension (Dallas, Tex. : 1979)

Nonn O, Fischer C, Geisberger S, El-Heliebi A, Kroneis T, Forstner D, Desoye G, Staff AC, Sugulle M, Dechend R, Pecks U, Kollmann M, Stern C, Cartwright JE, Whitley GS, Thilaganathan B, Wadsack C, Huppertz B, Herse F, Gauster M.
PMID: 33775117
Hypertension. 2021 May 05;77(5):1723-1736. doi: 10.1161/HYPERTENSIONAHA.120.16425. Epub 2021 Mar 29.

[Figure: see text].

Cite
Nonn O, Fischer C, Geisberger S, et al. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia. Hypertension. 2021;77(5):1723-1736doi: 10.1161/HYPERTENSIONAHA.120.16425.
Nonn, O., Fischer, C., Geisberger, S., El-Heliebi, A., Kroneis, T., Forstner, D., Desoye, G., Staff, A. C., Sugulle, M., Dechend, R., Pecks, U., Kollmann, M., Stern, C., Cartwright, J. E., Whitley, G. S., Thilaganathan, B., Wadsack, C., Huppertz, B., Herse, F., & Gauster, M. (2021). Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia. Hypertension (Dallas, Tex. : 1979), 77(5), 1723-1736. https://doi.org/10.1161/HYPERTENSIONAHA.120.16425
Nonn, Olivia, et al. "Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia." Hypertension (Dallas, Tex. : 1979) vol. 77,5 (2021): 1723-1736. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.16425
Nonn O, Fischer C, Geisberger S, El-Heliebi A, Kroneis T, Forstner D, Desoye G, Staff AC, Sugulle M, Dechend R, Pecks U, Kollmann M, Stern C, Cartwright JE, Whitley GS, Thilaganathan B, Wadsack C, Huppertz B, Herse F, Gauster M. Maternal Angiotensin Increases Placental Leptin in Early Gestation via an Alternative Renin-Angiotensin System Pathway: Suggesting a Link to Preeclampsia. Hypertension. 2021 May 05;77(5):1723-1736. doi: 10.1161/HYPERTENSIONAHA.120.16425. Epub 2021 Mar 29. PMID: 33775117.
Copy Download .nbib Format: NLM
TAPAS: An Open-Source Software Package for Translational Neuromodeling and Computational Psychiatry.

Frontiers in psychiatry

Frässle S, Aponte EA, Bollmann S, Brodersen KH, Do CT, Harrison OK, Harrison SJ, Heinzle J, Iglesias S, Kasper L, Lomakina EI, Mathys C, Müller-Schrader M, Pereira I, Petzschner FH, Raman S, Schöbi D, Toussaint B, Weber LA, Yao Y, Stephan KE.
PMID: 34149484
Front Psychiatry. 2021 Jun 02;12:680811. doi: 10.3389/fpsyt.2021.680811. eCollection 2021.

Psychiatry faces fundamental challenges with regard to mechanistically guided differential diagnosis, as well as prediction of clinical trajectories and treatment response of individual patients. This has motivated the genesis of two closely intertwined fields: (i) Translational Neuromodeling (TN), which...

Cite
Frässle S, Aponte EA, Bollmann S, et al. TAPAS: An Open-Source Software Package for Translational Neuromodeling and Computational Psychiatry. Front Psychiatry. 2021;12:680811doi: 10.3389/fpsyt.2021.680811.
Frässle, S., Aponte, E. A., Bollmann, S., Brodersen, K. H., Do, C. T., Harrison, O. K., Harrison, S. J., Heinzle, J., Iglesias, S., Kasper, L., Lomakina, E. I., Mathys, C., Müller-Schrader, M., Pereira, I., Petzschner, F. H., Raman, S., Schöbi, D., Toussaint, B., Weber, L. A., Yao, Y., & Stephan, K. E. (2021). TAPAS: An Open-Source Software Package for Translational Neuromodeling and Computational Psychiatry. Frontiers in psychiatry, 12680811. https://doi.org/10.3389/fpsyt.2021.680811
Frässle, Stefan, et al. "TAPAS: An Open-Source Software Package for Translational Neuromodeling and Computational Psychiatry." Frontiers in psychiatry vol. 12 (2021): 680811. doi: https://doi.org/10.3389/fpsyt.2021.680811
Frässle S, Aponte EA, Bollmann S, Brodersen KH, Do CT, Harrison OK, Harrison SJ, Heinzle J, Iglesias S, Kasper L, Lomakina EI, Mathys C, Müller-Schrader M, Pereira I, Petzschner FH, Raman S, Schöbi D, Toussaint B, Weber LA, Yao Y, Stephan KE. TAPAS: An Open-Source Software Package for Translational Neuromodeling and Computational Psychiatry. Front Psychiatry. 2021 Jun 02;12:680811. doi: 10.3389/fpsyt.2021.680811. eCollection 2021. PMID: 34149484; PMCID: PMC8206497.
Copy Download .nbib Format: NLM
Price and income effects of hospital reimbursements.

Journal of health economics

Bäuml M, Dette T, Pollmann M.
PMID: 34923343
J Health Econ. 2021 Dec 10;81:102576. doi: 10.1016/j.jhealeco.2021.102576. Epub 2021 Dec 10.

Health insurance systems in many countries reimburse hospitals through fixed prices based on the diagnosis-related groups (DRGs) of patients. We quantify the effects of price and income changes for the full spectrum of hospital services as average and heterogeneous...

Cite
Bäuml M, Dette T, Pollmann M. Price and income effects of hospital reimbursements. J Health Econ. 2021;81:102576doi: 10.1016/j.jhealeco.2021.102576.
Bäuml, M., Dette, T., & Pollmann, M. (2021). Price and income effects of hospital reimbursements. Journal of health economics, 81102576. https://doi.org/10.1016/j.jhealeco.2021.102576
Bäuml, Matthias, et al. "Price and income effects of hospital reimbursements." Journal of health economics vol. 81 (2021): 102576. doi: https://doi.org/10.1016/j.jhealeco.2021.102576
Bäuml M, Dette T, Pollmann M. Price and income effects of hospital reimbursements. J Health Econ. 2021 Dec 10;81:102576. doi: 10.1016/j.jhealeco.2021.102576. Epub 2021 Dec 10. PMID: 34923343.
Copy Download .nbib Format: NLM
Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine.

Nature

Rajewsky N, Almouzni G, Gorski SA, Aerts S, Amit I, Bertero MG, Bock C, Bredenoord AL, Cavalli G, Chiocca S, Clevers H, De Strooper B, Eggert A, Ellenberg J, Fernández XM, Figlerowicz M, Gasser SM, Hubner N, Kjems J, Knoblich JA, Krabbe G, Lichter P, Linnarsson S, Marine JC, Marioni JC, Marti-Renom MA, Netea MG, Nickel D, Nollmann M, Novak HR, Parkinson H, Piccolo S, Pinheiro I, Pombo A, Popp C, Reik W, Roman-Roman S, Rosenstiel P, Schultze JL, Stegle O, Tanay A, Testa G, Thanos D, Theis FJ, Torres-Padilla ME, Valencia A, Vallot C, van Oudenaarden A, Vidal M, Voet T.
PMID: 33731935
Nature. 2021 Apr;592(7852):E8. doi: 10.1038/s41586-021-03287-8.

No abstract available.

Cite
Rajewsky N, Almouzni G, Gorski SA, et al. Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine. Nature. 2021;592(7852):E8doi: 10.1038/s41586-021-03287-8.
Rajewsky, N., Almouzni, G., Gorski, S. A., Aerts, S., Amit, I., Bertero, M. G., Bock, C., Bredenoord, A. L., Cavalli, G., Chiocca, S., Clevers, H., De Strooper, B., Eggert, A., Ellenberg, J., Fernández, X. M., Figlerowicz, M., Gasser, S. M., Hubner, N., Kjems, J., Knoblich, J. A., Krabbe, G., Lichter, P., Linnarsson, S., Marine, J. C., Marioni, J. C., Marti-Renom, M. A., Netea, M. G., Nickel, D., Nollmann, M., Novak, H. R., Parkinson, H., Piccolo, S., Pinheiro, I., Pombo, A., Popp, C., Reik, W., Roman-Roman, S., Rosenstiel, P., Schultze, J. L., Stegle, O., Tanay, A., Testa, G., Thanos, D., Theis, F. J., Torres-Padilla, M. E., Valencia, A., Vallot, C., van Oudenaarden, A., Vidal, M., Voet, T. (2021). Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine. Nature, 592(7852), E8. https://doi.org/10.1038/s41586-021-03287-8
Rajewsky, Nikolaus, et al. "Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine." Nature vol. 592,7852 (2021): E8. doi: https://doi.org/10.1038/s41586-021-03287-8
Rajewsky N, Almouzni G, Gorski SA, Aerts S, Amit I, Bertero MG, Bock C, Bredenoord AL, Cavalli G, Chiocca S, Clevers H, De Strooper B, Eggert A, Ellenberg J, Fernández XM, Figlerowicz M, Gasser SM, Hubner N, Kjems J, Knoblich JA, Krabbe G, Lichter P, Linnarsson S, Marine JC, Marioni JC, Marti-Renom MA, Netea MG, Nickel D, Nollmann M, Novak HR, Parkinson H, Piccolo S, Pinheiro I, Pombo A, Popp C, Reik W, Roman-Roman S, Rosenstiel P, Schultze JL, Stegle O, Tanay A, Testa G, Thanos D, Theis FJ, Torres-Padilla ME, Valencia A, Vallot C, van Oudenaarden A, Vidal M, Voet T. Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine. Nature. 2021 Apr;592(7852):E8. doi: 10.1038/s41586-021-03287-8. PMID: 33731935; PMCID: PMC8009763.
Copy Download .nbib Format: NLM
SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Leiner J, Pellissier V, Nitsche A, König S, Hohenstein S, Nachtigall I, Hindricks G, Kutschker C, Rolinski B, Gebauer J, Prantz A, Schubert J, Patzschke J, Bollmann A, Wolz M.
PMID: 34517045
Int J Infect Dis. 2021 Nov;112:117-123. doi: 10.1016/j.ijid.2021.09.008. Epub 2021 Sep 10.

OBJECTIVES: SARS-CoV-2 rapid antigen tests (RAT) provide fast identification of infectious patients when RT-PCR results are not immediately available. We aimed to develop a prediction model for identification of false negative (FN) RAT results.METHODS: In this multicenter trial, patients...

Cite
Leiner J, Pellissier V, Nitsche A, et al. SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results. Int J Infect Dis. 2021;112:117-123doi: 10.1016/j.ijid.2021.09.008.
Leiner, J., Pellissier, V., Nitsche, A., König, S., Hohenstein, S., Nachtigall, I., Hindricks, G., Kutschker, C., Rolinski, B., Gebauer, J., Prantz, A., Schubert, J., Patzschke, J., Bollmann, A., & Wolz, M. (2021). SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 112117-123. https://doi.org/10.1016/j.ijid.2021.09.008
Leiner, Johannes, et al. "SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results." International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases vol. 112 (2021): 117-123. doi: https://doi.org/10.1016/j.ijid.2021.09.008
Leiner J, Pellissier V, Nitsche A, König S, Hohenstein S, Nachtigall I, Hindricks G, Kutschker C, Rolinski B, Gebauer J, Prantz A, Schubert J, Patzschke J, Bollmann A, Wolz M. SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results. Int J Infect Dis. 2021 Nov;112:117-123. doi: 10.1016/j.ijid.2021.09.008. Epub 2021 Sep 10. PMID: 34517045; PMCID: PMC8431843.
Copy Download .nbib Format: NLM
Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis.

Molecular psychiatry

Wilke JBH, Hindermann M, Berghoff SA, Zihsler S, Arinrad S, Ronnenberg A, Barnkothe N, Steixner-Kumar AA, Röglin S, Stöcker W, Hollmann M, Nave KA, Lühder F, Ehrenreich H.
PMID: 34331009
Mol Psychiatry. 2021 Jul 30; doi: 10.1038/s41380-021-01238-3. Epub 2021 Jul 30.

The etiology and pathogenesis of "anti-N-methyl-D-aspartate-receptor (NMDAR) encephalitis" and the role of autoantibodies (AB) in this condition are still obscure. While NMDAR1-AB exert NMDAR-antagonistic properties by receptor internalization, no firm evidence exists to date that NMDAR1-AB by themselves induce...

Cite
Wilke JBH, Hindermann M, Berghoff SA, et al. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Mol Psychiatry. 2021;doi: 10.1038/s41380-021-01238-3.
Wilke, J. B. H., Hindermann, M., Berghoff, S. A., Zihsler, S., Arinrad, S., Ronnenberg, A., Barnkothe, N., Steixner-Kumar, A. A., Röglin, S., Stöcker, W., Hollmann, M., Nave, K. A., Lühder, F., & Ehrenreich, H. (2021). Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Molecular psychiatry, . https://doi.org/10.1038/s41380-021-01238-3
Wilke, Justus B H, et al. "Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis." Molecular psychiatry vol. (2021). doi: https://doi.org/10.1038/s41380-021-01238-3
Wilke JBH, Hindermann M, Berghoff SA, Zihsler S, Arinrad S, Ronnenberg A, Barnkothe N, Steixner-Kumar AA, Röglin S, Stöcker W, Hollmann M, Nave KA, Lühder F, Ehrenreich H. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis. Mol Psychiatry. 2021 Jul 30; doi: 10.1038/s41380-021-01238-3. Epub 2021 Jul 30. PMID: 34331009.
Copy Download .nbib Format: NLM
A Complementary and Revised View on the N-Acylation of Chitosan with Hexanoyl Chloride.

Marine drugs

Reis B, Gerlach N, Steinbach C, Haro Carrasco K, Oelmann M, Schwarz S, Müller M, Schwarz D.
PMID: 34356810
Mar Drugs. 2021 Jul 02;19(7). doi: 10.3390/md19070385.

The modification of the biobased polymer chitosan is a broad and widely studied field. Herein, an insight into the hydrophobization of low-molecular-weight chitosan by substitution of amino functionalities with hexanoyl chloride is reported. Thereby, the influence of the pH...

Cite
Reis B, Gerlach N, Steinbach C, et al. A Complementary and Revised View on the N-Acylation of Chitosan with Hexanoyl Chloride. Mar Drugs. 2021;19(7)doi: 10.3390/md19070385.
Reis, B., Gerlach, N., Steinbach, C., Haro Carrasco, K., Oelmann, M., Schwarz, S., Müller, M., & Schwarz, D. (2021). A Complementary and Revised View on the N-Acylation of Chitosan with Hexanoyl Chloride. Marine drugs, 19(7), . https://doi.org/10.3390/md19070385
Reis, Berthold, et al. "A Complementary and Revised View on the N-Acylation of Chitosan with Hexanoyl Chloride." Marine drugs vol. 19,7 (2021). doi: https://doi.org/10.3390/md19070385
Reis B, Gerlach N, Steinbach C, Haro Carrasco K, Oelmann M, Schwarz S, Müller M, Schwarz D. A Complementary and Revised View on the N-Acylation of Chitosan with Hexanoyl Chloride. Mar Drugs. 2021 Jul 02;19(7). doi: 10.3390/md19070385. PMID: 34356810; PMCID: PMC8303196.
Copy Download .nbib Format: NLM
Factors influencing publication of scientific articles derived from masters theses in public health.

Hollmann M, Borrell C, Garin O, Fernandez E, Alonso J.
UIID-AD: 241
2015;60:495-504. doi: 10.1007/s00038-015-0664-0.

To evaluate theses of a Masters program in Public Health (MPH), in terms of the students' and theses' characteristics that influence publication of the thesis as a scientific article. Longitudinal study of students who successfully completed the MPH at...

Cite
Hollmann M, Borrell C, Garin O, et al. Factors influencing publication of scientific articles derived from masters theses in public health. 2015;60:495-504doi: 10.1007/s00038-015-0664-0.
Hollmann, M., Borrell, C., Garin, O., Fernandez, E., & Alonso, J. (2015). Factors influencing publication of scientific articles derived from masters theses in public health. 60495-504. https://doi.org/10.1007/s00038-015-0664-0
Hollmann, M, et al. "Factors influencing publication of scientific articles derived from masters theses in public health." vol. 60 (2015): 495-504. doi: https://doi.org/10.1007/s00038-015-0664-0
Hollmann M, Borrell C, Garin O, Fernandez E, Alonso J. Factors influencing publication of scientific articles derived from masters theses in public health. 2015;60:495-504. doi: 10.1007/s00038-015-0664-0. UIID-AD: 241.
Copy Download .nbib Format: NLM
Showing 301 to 308 of 308 entries